ISPC (iSpecimen) Tariff Resilience Score: 6/10 (As of Jul. 01, 2026)


ISPC iSpecimen Inc ISPC
49 GF Score
Price $2.65
GF Value $6.70
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is iSpecimen Tariff Resilience Score?

iSpecimen ISPC -3.81% 49 Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus rates ISPC with a GF Score™ of 49/100 and a GF Value™ of $6.70 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, iSpecimen ranks better than 87.44% on this metric.

iSpecimen has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

iSpecimen has Healthcare specimen marketplace with moderate exposure to tariffs on medical goods. Relies on global supply chains but can mitigate through diverse supplier base and digital platform advantages.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes iSpecimen might have Average Resilient.

iSpecimen  (NAS:ISPC) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

iSpecimen Tariff Resilience Score Related Terms

ISPC vs BIAF, FUNI, IVRO: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, iSpecimen's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iSpecimen Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, iSpecimen's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where iSpecimen's Tariff Resilience Score falls into.


ISPC
49GF Score
iSpecimen Inc ISPC
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
iSpecimen (ISPC) has a Tariff Resilience Score of 6 as of Jul. 01, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, iSpecimen ranks #27 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 12.6%.
Is iSpecimen's Tariff Resilience Score too high?
iSpecimen's current Tariff Resilience Score is 6. Based on the distribution chart, iSpecimen ranks #27 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, iSpecimen has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does iSpecimen's Tariff Resilience Score compare to BIAF and FUNI?
According to the Medical Diagnostics & Research industry distribution chart, iSpecimen ranks #27 out of 215 companies for Tariff Resilience Score. This places iSpecimen in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. iSpecimen's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iSpecimen stock overvalued right now?
Based on GuruFocus' analysis, iSpecimen (ISPC) is currently considered Possible Value Trap. The stock's GF Value™ is $6.70, compared to a current price of $2.65 — trading 60.5% below its estimated fair value. The current Tariff Resilience Score is 6. iSpecimen's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For iSpecimen (ISPC), the current Tariff Resilience Score is 6 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iSpecimen (ISPC) Overvalued in 2026?

Based on GuruFocus' analysis, iSpecimen stock appears to be undervalued. The current stock price of $2.65 is trading 60.5% below its estimated GF Value™ of $6.70. GuruFocus considers iSpecimen to be Possible Value Trap.

Key valuation signals for ISPC:

  • Tariff Resilience Score: 6
  • GF Value™: $6.70 vs. price of $2.65 (60.5% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the ISPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iSpecimen Business Description

Address 8 Cabot Road, Suite 1800, Woburn, MA, USA, 01801
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
49GF Score

Get the complete analysis for ISPC

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.65
Price
$6.70
GF Value